The Video System to Provide a Developmental Training Guide for Preterm Infants

September 11, 2025 updated by: Woo Hyung Lee, Seoul National University Hospital

The Video System to Provide a Developmental Training Guide for In-home, Parent-centered, Early Intervention in Preterm Infants: A Proof of Concept and Feasibility Study

This study aimed to establish a systematic developmental training guide protocol for parent-centered early intervention and verify the concept and feasibility of a video system for parent-centered in-home developmental therapy under the monitoring of a therapist. The target group is premature infants under 32 weeks of gestation or very low birth weight infants under 1500 g with brain damage. A single-arm intervention group of 10 people was recruited, and considering a dropout rate of 20%, the total number of participants was calculated to be 12. 1:1 monitoring to provide parent-centered early intervention at home after discharge from the neonatal intensive care unit is conducted twice a week for 30 minutes per session using a video platform (Zoom) until the corrected age of 6 months. Parents record the developmental training process using a smartphone and transmit it to the therapist, who analyzes the video data to provide new treatment goals and guidelines. Feasibility assessment included: 1) Exercise diary: Number of total and average sessions performed (N) and percentage (%), number of total and average sessions completed (N) and percentage (%) 2) Parent questionnaire 3) Video analysis: Periodic video education and developmental training video acquisition and analysis 4) Heart rate analysis: Analysis of average heart rate during and after rest and developmental training 5) Safety analysis: Number of times (N) and reasons for exercise interruption during developmental training 6) Developmental assessment: Implementation of developmental assessments such as GMOS, MOS-R, HINE, GMFM, and BSID. For safety assessment, if the following symptoms appear during development training, stop exercising and rest until stable. If oxygen saturation drops by more than 10% compared to resting, causing cyanosis and dyspnea, or if heart rate increases by more than 150 beats/min.

Study Overview

Status

Enrolling by invitation

Study Type

Interventional

Enrollment (Estimated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jongno-gu
      • Seoul, Jongno-gu, South Korea, 03080
        • Seoul National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Premature infants less than 32 weeks of gestation or extremely low birth weight infants less than 1500 g
  • Premature infants with a corrected age of less than 1 month
  • Brain damage through brain imaging (e.g. cranial USG, brain MRI)

Exclusion Criteria:

  • Multiple malformations or genetic abnormalities
  • Severe visual or hearing impairment
  • Loss of consciousness
  • Tracheostomy
  • Medically unstable condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention
After discharge from the neonatal intensive care unit, 1:1 monitoring is conducted at home for 30 minutes twice a week using a video conferencing platform (Zoom) until the corrected age of 6 months to provide parent-centered early intervention. Parents film the developmental training process using a smartphone and send the video to the therapist, who analyzes the video data to provide new treatment goals and guidelines.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of total and average sessions performed (N)
Time Frame: up to corrected age 6 months
up to corrected age 6 months
Percentage of total and average sessions performed (%)
Time Frame: up to corrected age 6 months
up to corrected age 6 months
Number of total and average sessions completed (N)
Time Frame: up to corrected age 6 months
up to corrected age 6 months
Percentage of total and average sessions completed (%)
Time Frame: up to corrected age 6 months
up to corrected age 6 months
Parent questionnaire
Time Frame: at corrected age 6 months
at corrected age 6 months
General Movement Optimality Score
Time Frame: corrected age 0, 1.5months
Minimum score: 5 Maximum score: 42 Assessing the quality of writhing movements in infants (typically from term age to 6-9 weeks post-term). Higher scores reflect more optimal general movements - smooth, variable, and age-appropriate. Lower scores may suggest abnormal or poor-quality movements, which are associated with neurological risk.
corrected age 0, 1.5months
Motor Optimality Score-Revised
Time Frame: corrected age 4months

Minimum score: 5 Maximum score: 28

Evaluating fidgety movements and other spontaneous motor patterns in infants (typically from 9 to 20 weeks post-term). Higher scores indicate better motor repertoire and neurological function, and are associated with typical development. Lower scores are often seen in infants at risk for motor disorders, such as cerebral palsy.

corrected age 4months
Hammersmith Infant Neurological Examination
Time Frame: corrected age 4, 6, 9 months

Total Score Range:

Minimum: 0 Maximum: 78

The total score is the sum of scores across 26 items, each scored from 0 to 3:

0 = severely abnormal

  1. = moderately abnormal
  2. = mildly abnormal
  3. = normal Higher HINE scores (closer to 78) indicate better neurological function. Lower scores may suggest neurological impairment or risk for conditions such as cerebral palsy.
corrected age 4, 6, 9 months
Gross Motor Function Measure
Time Frame: corrected age 6, 9 months

GMFM-88

Items: 88 items across 5 dimensions:

Lying and Rolling Sitting Crawling and Kneeling Standing Walking, Running, and Jumping Scoring per item: 0 to 3

Total Score Range:

Minimum: 0% Maximum: 100% (Expressed as a percentage of the maximum possible score) Higher scores represent better gross motor function.

corrected age 6, 9 months
Bayley Scales of Infant and Toddler Development
Time Frame: corrected age 9 months
  1. Scaled Scores (for subtests like Fine Motor, Expressive Language, etc.):

    Range:

    Minimum: 1 Maximum: 19 Mean: 10 Standard Deviation (SD): 3

  2. Composite Scores (for broader domains like Cognitive, Motor, etc.):

Range:

Minimum: 40 Maximum: 160 Mean: 100 Standard Deviation (SD): 15 130 and above Very Superior 120-129 Superior 110-119 High Average 90-109 Average 80-89 Low Average 70-79 Borderline Below 70 Extremely Low / Delayed

corrected age 9 months
Number of exercise interruption (N)
Time Frame: up to corrected age 6 months
up to corrected age 6 months
Number of adverse event (N)
Time Frame: up to corrected age 6 months
up to corrected age 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2025

Primary Completion (Estimated)

January 30, 2026

Study Completion (Estimated)

January 30, 2028

Study Registration Dates

First Submitted

April 21, 2025

First Submitted That Met QC Criteria

May 2, 2025

First Posted (Actual)

May 11, 2025

Study Record Updates

Last Update Posted (Estimated)

September 17, 2025

Last Update Submitted That Met QC Criteria

September 11, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe